← back to search

Matthew R. Redinbo

University of North Carolina at Chapel Hill · US
Area of research
Molecular Biology · Pharmacology
Research interest
Research interests include Gut microbiota and health, Pharmacogenetics and Drug Metabolism, Cancer therapeutics and mechanisms, and Cholinesterase and Neurodegenerative Diseases.
h-index
68
citations
18,014
works
366
NIH funding
primary concept
Chemistry
email

Recent publications

Weight loss and omega-3 supplementation modulate the microbiome in women with increased breast cancer risk.
2026cited by 0position: contributordoi
Glucuronidation metabolomic fingerprinting to map host-microbe metabolism
Nature Communications 2026cited by 0position: contributordoi
Gut Microbiota Mediate the Metabolism of Colonic Prostaglandins
2026cited by 0position: contributordoi
Microbiota and kidney disease: the road ahead
Nature Reviews Nephrology 2025cited by 18position: middledoi
Emerging gut microbial glycoside hydrolase inhibitors.
2025cited by 2position: contributordoi
Glucuronidation Metabolomic Fingerprinting to Map Host-Microbe Metabolism
2025cited by 2position: contributordoi
Sex-Dependent Responses in Mice to Indomethacin-Induced Injury and Gut Microbiome-Targeted Alleviation
2025cited by 0position: contributordoi
Commercially Purchased and In-House Bred C57BL/6 Mice with Different Gut Microbiota Exhibit Distinct Indomethacin-Induced Toxicities.
2025cited by 0position: contributordoi
Commercially Purchased and In-House Bred C57BL/6 Mice with Different Gut Microbiota Exhibit Distinct Indomethacin-Induced Toxicities
2025cited by 0position: contributordoi
The role of gut microbial β-glucuronidases in carcinogenesis and cancer treatment: a scoping review.
2024cited by 8position: contributordoi
Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity.
2024cited by 1position: contributordoi
Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut
Nature Microbiology 2023cited by 166position: middledoi
Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut.
2023cited by 141position: contributordoi
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate.
2023cited by 27position: contributordoi
Microbial β-glucuronidases drive human periodontal disease etiology.
2023cited by 19position: contributordoi
Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response.
2023cited by 17position: contributordoi
Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development
Cell chemical biology 2023cited by 3position: middledoi
Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract
Nature Communications 2022cited by 107position: middledoi
Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract
Nature Communications 2022cited by 91position: contributordoi
Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome.
2022cited by 70position: contributordoi
Diverse MarR bacterial regulators of auxin catabolism in the plant microbiome
Nature Microbiology 2022cited by 44position: middledoi
Diverse MarR bacterial regulators of auxin catabolism in the plant microbiome.
2022cited by 35position: contributordoi
Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate.
2022cited by 32position: contributordoi
A structural metagenomics pipeline for examining the gut microbiome.
2022cited by 24position: contributordoi
Multi-omic analysis of host-microbial interactions central to the gut-brain axis.
2022cited by 3position: contributordoi
The <i>in vitro</i> metabolism and <i>in vivo</i> pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652.
2022cited by 1position: contributordoi
Metagenomics Combined with Activity-Based Proteomics Point to Gut Bacterial Enzymes that Reactivate Mycophenolate
2022cited by 0position: contributordoi
Reporting guidelines for human microbiome research: the STORMS checklist
Nature Medicine 2021cited by 456position: middledoi
Plant “helper” immune receptors are Ca <sup>2+</sup> -permeable nonselective cation channels
Science 2021cited by 378position: middledoi
Plant "helper" immune receptors are Ca<sup>2+</sup>-permeable nonselective cation channels.
2021cited by 309position: contributordoi

Grants

Macromolecular Crowding and Protein Stability In Vitro and in Cells
NSF1051819$792,5972011–2014PIRePORTER
Spin Chemistry and Radical Dynamics in Confined Environments: From Nanocrystals to Nanobubbles
NSF1111873$636,1902011–2016PIRePORTER
Macromolecular, Supramolecular, and Biological Free Radical Chemistry
NSF0809530$497,0002008–2011PIRePORTER

Frequent collaborators

· 32 papers (2019–2026)Joshua B. Simpson · University of North Carolina at Chapel Hill6 papers (2022–2026)Jeffery L. Dangl · University of North Carolina at Chapel Hill4 papers (2021–2022)Amanda L. Graboski · University of North Carolina at Chapel Hill4 papers (2020–2024)Jianan Zhang · University of Massachusetts Amherst4 papers (2022–2025)Sridhar Mani · Albert Einstein College of Medicine3 papers (2014–2019) · 3 papers (2021–2023)Adam D. Lietzan · University of North Carolina at Chapel Hill3 papers (2021–2023)Aadra P. Bhatt · College of Charleston3 papers (2020–2025)Pieter C. Dorrestein · University of Connecticut3 papers (2023–2026)Josh J. Sekela · Redinbo Lab3 papers (2025–2026)Ajay S. Gulati · University of North Carolina at Chapel Hill3 papers (2023–2025)William G. Walton · Imperial College Healthcare NHS Trust2 papers (2021–2022)Rani S. Sellers · University of North Carolina at Chapel Hill2 papers (2025–2025)Gary D. Wu · Department of Agriculture2 papers (2025–2026)Mark Zeller · Scripps Research Institute2 papers (2025–2025)Aadra P. Bhatt · University of North Carolina at Chapel Hill2 papers (2017–2017)William G. Walton · University of North Carolina at Chapel Hill2 papers (2021–2023)Mingxun Wang · University of California, Riverside2 papers (2025–2026)Guodong Zhang · Nanjing University of Chinese Medicine2 papers (2022–2026)